Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 183

    1.

    Skeletal muscle lipid content and oxidative enzyme activity in relation to muscle fiber type in type 2 diabetes and obesity.

    He J, Watkins S, Kelley DE.

    Diabetes. 2001 Apr;50(4):817-23.PMID: 11289047 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Altered fiber distribution and fiber-specific glycolytic and oxidative enzyme activity in skeletal muscle of patients with type 2 diabetes.

    Oberbach A, Bossenz Y, Lehmann S, Niebauer J, Adams V, Paschke R, Schön MR, Blüher M, Punkt K.

    Diabetes Care. 2006 Apr;29(4):895-900.PMID: 16567834 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Intramuscular lipid content is increased in obesity and decreased by weight loss.

    Goodpaster BH, Theriault R, Watkins SC, Kelley DE.

    Metabolism. 2000 Apr;49(4):467-72.PMID: 10778870 [PubMed - indexed for MEDLINE]Related articles

    4.

    GLUT4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease?

    Gaster M, Staehr P, Beck-Nielsen H, Schrøder HD, Handberg A.

    Diabetes. 2001 Jun;50(6):1324-9.PMID: 11375332 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM.

    Simoneau JA, Kelley DE.

    J Appl Physiol. 1997 Jul;83(1):166-71.PMID: 9216960 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Muscle glycogen content in type 2 diabetes mellitus.

    He J, Kelley DE.

    Am J Physiol Endocrinol Metab. 2004 Nov;287(5):E1002-7. Epub 2004 Jul 13.PMID: 15251866 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.

    Kelley DE, He J, Menshikova EV, Ritov VB.

    Diabetes. 2002 Oct;51(10):2944-50.PMID: 12351431 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Abnormal glucose transport and GLUT1 cell-surface content in fibroblasts and skeletal muscle from NIDDM and obese subjects.

    Miele C, Formisano P, Condorelli G, Caruso M, Oriente F, Andreozzi F, Tocchetti CG, Riccardi G, Beguinot F.

    Diabetologia. 1997 Apr;40(4):421-9.PMID: 9112019 [PubMed - indexed for MEDLINE]Related articles

    9.

    GLUT4 expression in human muscle fibres is not correlated with intracellular triglyceride (TG) content. Is TG a maker or a marker of insulin resistance?

    Gaster M, Ottosen PD, Vach W, Christiansen H, Staehr P, Beck-Nielsen H, Schrøder HD.

    APMIS. 2003 Feb;111(2):338-48.PMID: 12716391 [PubMed - indexed for MEDLINE]Related articles

    10.

    Fat content in individual muscle fibers of lean and obese subjects.

    Malenfant P, Joanisse DR, Thériault R, Goodpaster BH, Kelley DE, Simoneau JA.

    Int J Obes Relat Metab Disord. 2001 Sep;25(9):1316-21.PMID: 11571593 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus.

    Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P.

    Int J Obes (Lond). 2007 Aug;31(8):1302-10. Epub 2007 Feb 20.PMID: 17310221 [PubMed - indexed for MEDLINE]Related articles

    12.

    Metabolic profile and nitric oxide synthase expression of skeletal muscle fibers are altered in patients with type 1 diabetes.

    Fritzsche K, Blüher M, Schering S, Buchwalow IB, Kern M, Linke A, Oberbach A, Adams V, Punkt K.

    Exp Clin Endocrinol Diabetes. 2008 Nov;116(10):606-13. Epub 2008 May 9.PMID: 18465682 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes.

    Mogensen M, Sahlin K, Fernström M, Glintborg D, Vind BF, Beck-Nielsen H, Højlund K.

    Diabetes. 2007 Jun;56(6):1592-9. Epub 2007 Mar 9.PMID: 17351150 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.

    Kelley DE, Simoneau JA.

    J Clin Invest. 1994 Dec;94(6):2349-56.PMID: 7989591 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.

    Bruce CR, Anderson MJ, Carey AL, Newman DG, Bonen A, Kriketos AD, Cooney GJ, Hawley JA.

    J Clin Endocrinol Metab. 2003 Nov;88(11):5444-51.PMID: 14602787 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content.

    Goodpaster BH, Kelley DE, Thaete FL, He J, Ross R.

    J Appl Physiol. 2000 Jul;89(1):104-10.PMID: 10904041 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Insulin treatment increases skeletal muscle fibre area in patients with diabetes mellitus type 2.

    Cederholm T, Sylvén C, Esbjörnsson-Liljedahl M, Jansson E.

    Clin Physiol. 2000 Sep;20(5):354-9.PMID: 10971546 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of weight loss on muscle lipid content in morbidly obese subjects.

    Gray RE, Tanner CJ, Pories WJ, MacDonald KG, Houmard JA.

    Am J Physiol Endocrinol Metab. 2003 Apr;284(4):E726-32. Epub 2002 Dec 17.PMID: 12488242 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Intramyocellular lipid content in type 2 diabetes patients compared with overweight sedentary men and highly trained endurance athletes.

    van Loon LJ, Koopman R, Manders R, van der Weegen W, van Kranenburg GP, Keizer HA.

    Am J Physiol Endocrinol Metab. 2004 Sep;287(3):E558-65. Epub 2004 May 27.PMID: 15165998 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data